TW336934B - N-(3-benzofuranyl) urea-derivatives - Google Patents

N-(3-benzofuranyl) urea-derivatives

Info

Publication number
TW336934B
TW336934B TW085102648A TW85102648A TW336934B TW 336934 B TW336934 B TW 336934B TW 085102648 A TW085102648 A TW 085102648A TW 85102648 A TW85102648 A TW 85102648A TW 336934 B TW336934 B TW 336934B
Authority
TW
Taiwan
Prior art keywords
carbon atoms
branched chain
straight chain
alkyl
represent
Prior art date
Application number
TW085102648A
Other languages
English (en)
Inventor
Braunlich Gabriele
Fischer Rudiger
Es-Sayed Mazen
Henning Rolf
Sperzel Michael
Schlemmer Karl-Heinz
Nielsch Ulrich
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of TW336934B publication Critical patent/TW336934B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Cosmetics (AREA)
TW085102648A 1995-03-06 1996-03-05 N-(3-benzofuranyl) urea-derivatives TW336934B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504460.8A GB9504460D0 (en) 1995-03-06 1995-03-06 N-(3-Benzofuranyl)urea-derivatives

Publications (1)

Publication Number Publication Date
TW336934B true TW336934B (en) 1998-07-21

Family

ID=10770709

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085102648A TW336934B (en) 1995-03-06 1996-03-05 N-(3-benzofuranyl) urea-derivatives

Country Status (42)

Country Link
US (2) US6399657B1 (zh)
EP (1) EP0731099B1 (zh)
JP (1) JP3204901B2 (zh)
KR (2) KR100405579B1 (zh)
CN (2) CN1176651C (zh)
AR (1) AR002710A1 (zh)
AT (1) ATE193704T1 (zh)
BG (2) BG62732B1 (zh)
BR (1) BR9600930A (zh)
CA (1) CA2170824A1 (zh)
CO (1) CO4370145A1 (zh)
CZ (1) CZ66796A3 (zh)
DE (1) DE69608721T2 (zh)
DK (1) DK0731099T3 (zh)
DZ (1) DZ1998A1 (zh)
EE (1) EE03921B1 (zh)
ES (1) ES2147320T3 (zh)
FI (1) FI960998A (zh)
GB (1) GB9504460D0 (zh)
GR (1) GR3034240T3 (zh)
HK (1) HK1013285A1 (zh)
HR (1) HRP960071B1 (zh)
HU (1) HU222282B1 (zh)
IL (1) IL117349A (zh)
MA (1) MA23815A1 (zh)
MY (1) MY117526A (zh)
NO (1) NO313672B1 (zh)
NZ (1) NZ286107A (zh)
PE (1) PE43597A1 (zh)
PL (1) PL189206B1 (zh)
PT (1) PT731099E (zh)
RO (1) RO116622B1 (zh)
RU (1) RU2162845C2 (zh)
SI (1) SI0731099T1 (zh)
SK (1) SK281817B6 (zh)
SV (1) SV1996000015A (zh)
TN (1) TNSN96035A1 (zh)
TR (1) TR199600177A2 (zh)
TW (1) TW336934B (zh)
UA (1) UA46714C2 (zh)
YU (1) YU49359B (zh)
ZA (1) ZA961774B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en) * 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
JPH10168095A (ja) 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
WO2000027802A1 (en) * 1998-11-12 2000-05-18 Ariad Pharmaceuticals, Inc. Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
GB2350112A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active cycloalkyl ketones
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
GB2350109A (en) 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
GB2350110A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofurans
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
EP1478639A1 (en) 2002-02-22 2004-11-24 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
JP4206382B2 (ja) * 2002-11-19 2009-01-07 アキリオン ファーマシューティカルズ，インコーポレーテッド 置換されたアリールチオウレアおよび関連化合物；ウイルス複製のインヒビター
AU2003303678A1 (en) 2003-01-03 2004-08-10 Genzyme Corporation Urea derivatives and their use as anti-inflammatory agents
TW200528459A (en) * 2004-01-06 2005-09-01 Achillion Pharmaceuticals Inc Azabenzofuran substituted thioureas; inhibitors of viral replication
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2006137350A1 (ja) * 2005-06-22 2006-12-28 Kissei Pharmaceutical Co., Ltd. 新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
BRPI0713768A2 (pt) 2006-07-05 2012-10-30 Nycomed Gmbh combinação de inibidores de reductase de hmg-coa com inibidores de fosfodiesterase 4 para o tratamento de doenças pulmonares inflamatórias
US20140057978A1 (en) 2011-03-17 2014-02-27 Algiax Pharmaceuticals Gmbh Novel use of benzofuranylsulfonates
WO2013156232A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of benzofuranylsulfonates in neuropathic pain
JP6488000B2 (ja) 2014-03-18 2019-03-20 アルジアックス ファーマシューティカルズ ゲーエムベーハー ２−シアノ−３−シクロプロピル−３−ヒドロキシ−ｎ−アリール−チオアクリルアミド誘導体
EP3165224A1 (en) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
JP6788966B2 (ja) * 2015-12-24 2020-11-25 丸善製薬株式会社 化粧料
EP4020024A1 (en) 2020-12-22 2022-06-29 Paul Scherrer Institut Method for producing high aspect ratio fan-shaped optics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU559687B2 (en) * 1981-07-01 1987-03-19 Upjohn Company, The Pyridinyl-and imidazolyl-benzofurane and benzothiophenes
US4822803A (en) * 1983-10-31 1989-04-18 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
EP0146243A1 (en) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
US4933351A (en) * 1983-10-31 1990-06-12 Merck Frosst Canada, Inc. Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis
US5087638A (en) * 1984-06-20 1992-02-11 Merck Frosst Canada, Inc. Benzofuran derivatives
GB9200623D0 (en) * 1992-01-13 1992-03-11 Bayer Ag Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives

Also Published As

Publication number Publication date
UA46714C2 (uk) 2002-06-17
TR199600177A2 (tr) 1996-10-21
BR9600930A (pt) 1997-12-30
TNSN96035A1 (fr) 2005-03-15
PL189206B1 (pl) 2005-07-29
HU222282B1 (hu) 2003-05-28
DE69608721T2 (de) 2000-10-05
RO116622B1 (ro) 2001-04-30
EP0731099B1 (en) 2000-06-07
SI0731099T1 (en) 2000-08-31
YU49359B (sh) 2005-09-19
CO4370145A1 (es) 1996-10-07
BG100396A (bg) 1996-12-31
CN1134419A (zh) 1996-10-30
GR3034240T3 (en) 2000-12-29
NO313672B1 (no) 2002-11-11
GB9504460D0 (en) 1995-04-26
MA23815A1 (fr) 1996-10-01
NZ286107A (en) 1998-08-26
AU4582896A (en) 1996-09-19
US6399657B1 (en) 2002-06-04
CZ66796A3 (en) 1996-09-11
CN1313284A (zh) 2001-09-19
PL313070A1 (en) 1996-09-16
HRP960071A2 (en) 1997-12-31
NO960884L (no) 1996-09-09
HK1013285A1 (en) 1999-08-20
BG62732B1 (bg) 2000-06-30
NO960884D0 (no) 1996-03-05
ES2147320T3 (es) 2000-09-01
US20030109578A1 (en) 2003-06-12
EE03921B1 (et) 2002-12-16
SK281817B6 (sk) 2001-08-06
EE9600030A (et) 1996-10-15
MY117526A (en) 2004-07-31
PE43597A1 (es) 1997-12-26
PT731099E (pt) 2000-11-30
FI960998A0 (fi) 1996-03-04
IL117349A (en) 2002-09-12
JP3204901B2 (ja) 2001-09-04
KR100405579B1 (ko) 2004-03-19
HUP9600549A2 (en) 1997-07-28
US6677372B2 (en) 2004-01-13
KR960034194A (ko) 1996-10-22
SK29796A3 (en) 1996-10-02
KR100438633B1 (ko) 2004-07-02
YU13396A (sh) 1999-06-15
ATE193704T1 (de) 2000-06-15
CN1176651C (zh) 2004-11-24
AU705667B2 (en) 1999-05-27
SV1996000015A (es) 1997-02-17
ZA961774B (en) 1996-09-17
HU9600549D0 (en) 1996-04-29
DE69608721D1 (de) 2000-07-13
DZ1998A1 (fr) 2002-07-20
HRP960071B1 (en) 2001-04-30
JPH08253466A (ja) 1996-10-01
RU2162845C2 (ru) 2001-02-10
AR002710A1 (es) 1998-04-29
CA2170824A1 (en) 1996-09-07
EP0731099A1 (en) 1996-09-11
IL117349A0 (en) 1996-07-23
HUP9600549A3 (en) 1998-04-28
DK0731099T3 (da) 2000-09-25
FI960998A (fi) 1996-09-07

Similar Documents

Publication Publication Date Title
TW336934B (en) N-(3-benzofuranyl) urea-derivatives
DK0848703T3 (da) Derivater af benzosulfonamider som inhibitorer for enzymet cyclooxygenase II
DK0699191T3 (da) Sulfonamider og derivater deraf, der modulerer aktiviteten af endotelin
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
DK1214936T3 (da) Anvendelse af thiazolidin- eller pyrrolidinderivater af aminosyrer som antihyperglykæmiske midler
ATE248824T1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
GEP20043172B (en) Combination Chemotherapy
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
TW341571B (en) Sulfonamide derivatives of azolones
NO931366D0 (no) 1,2,4-oksadiazolylfenoksyalkylisoksazoler og deres anvendelse som antivirale midler
PL309281A1 (en) Derivatives of 1,4-benzodiazepine and their application as cck modulators
BR9909819A (pt) Amida, uso de amidas, e, preparação farmacêutica para uso oral, parenteral ou intraperitoneal
DK0699180T3 (da) Bicykliske amidderivater og anvendelse af disse som muskelafspændende midler
NO20002834D0 (no) S-oksyd og S,S-dioksyd-tetrahydrothiopyran- fenyloksazolidinoner
DK0618193T3 (da) Nitrogenholdige, bicycliske derivater som prolyl-endopeptidaseinhibitorer
AU569916B2 (en) Substituted 5-acylamino-1-phenylpyrazoles
ID23053A (id) Karboksamida yang digunakan sebagai agonis 5-ht <if>
DK0759027T3 (da) Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase
DK0843967T3 (da) Anvendelse af beta-aminopripionsyrederivater som fungicider
FR2705962B1 (fr) Arylpyrazoles fongicides.
DE60005689D1 (de) Neue aminobenzophenone
PT941975E (pt) Cimento para injeccao contendo inibidores de corrosao
BG104471A (en) Benzylidene pyrazolones, their preparation and use as herbicides
BR0307000A (pt) Compostos para modulação de proliferação celular
DE60331518D1 (de) Einen Diheteroarylmethan-Direkfarbstoff enthaltende Zusammensetzung zur Färbung von Keratinfasern und Färbeverfahren mit dieser Zusammensetzung